This page shows the latest COPD news and features for those working in and with pharma, biotech and healthcare.
Prior to the COVID-19 pandemic, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in
UK biotech had initially been testing drug for COPD and asthma. ... response. Initially, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in COVID-19
Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses compared to placebo. ... He added that, despite the encouraging data in COPD, this
If you smoke ten packs of cigarettes per day, you will likely suffer from emphysema or COPD or some other respiratory illness.
Triple respiratory drug Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is already approved in the EU and US for use in chronic obstructive pulmonary disease (COPD) patients, although GSK is now keen ... The expansion into asthma is also
It’s in-house R&D in this area is focused on vaccines against respiratory syncytial virus (RSV), bacteria that contribute to chronic obstructive pulmonary disease (COPD) and a new meningitis
More from news
Approximately 71 fully matching, plus 226 partially matching documents found.
The main disease areas of focus have understandably been chronic diseases, including obesity, diabetes, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
Interestingly, Howarth explained that a proportion of patients with COPD also have eosinophilic inflammation.
Spiolto – a LAMA/LABA combination for COPD and heir to Boehringer’s blockbuster Spiriva.
The software helps differentiate patients from those suffering with similar symptoms that are actually a result of asthma and chronic obstructive pulmonary disease (COPD), and therefore diagnose CTEPH more reliably and
Patient populations – trials with vulnerable populations (eg, the elderly, the immunocompromised, patients with pulmonary conditions such as COPD).
More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.
in development for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. ... for the maintenance treatment of COPD.”.
A potential first-in-class treatment for chronic obstructive pulmonary disease (COPD), Verona Pharma's RPL554 is being tested as a nebulised maintenance treatment for patients with moderate to severe disease.
Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
The Silver was awarded for ‘Breathing is everything’, an interactive video created for healthcare professionals that offers a live-action experience of what COPD patients go through on a daily basis.
There’s a whole array of podcasts about different conditions out there, from COPD to dementia.
We carried out a survey among patients who have any one of these conditions: chronic obstructive pulmonary disorder (COPD), ulcerative colitis (UC), Crohn’s disease (CD) and idiopathic pulmonary fibrosis (IPF). ... Very few respondents were currently
A key resource in this field is myCOPD - a specialist self-care app designed and built by COPD experts, and externally peer-reviewed by leading NHS consultants.
Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.
More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...